# Orthopediatrics Corp: filings

KIDS · Nasdaq · CIK 1425450 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kids.md) · [Financials](/companies/kids/financials.md) · [Filings](/companies/kids/filings.md) · [Insiders](/companies/kids/insiders.md)

## Reports and events: 213 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 268, 8-K 151, 10-Q 27, 3 20, SC 13G/A 16, UPLOAD 14, CORRESP 13, 10-K 9, 5 9, DEF 14A 9, DEFA14A 9, 144 8, 424B5 8, SC 13G 7, 3/A 6, 8-K/A 6, S-1/A 5, SCHEDULE 13G/A 5, EFFECT 4, D 3, S-3 3, ARS 2, DRS/A 2, DRSLTR 2, S-3MEF 2, S-8 2, SC 13D/A 2, SCHEDULE 13D/A 2, 424B4 1, 8-A12B 1, CERTNAS 1, D/A 1, DEFR14A 1, DRS 1, S-1 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:15 ET | [8-K](/filings/0001425450-26-000092.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000092 |
| 2026-10-27 | 16:07 ET | [8-K](/filings/0001425450-26-000091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000091 |
| 2026-09-11 | 08:44 ET | [SCHEDULE 13D/A](/filings/0001193125-26-388676.md) | Ownership report, active investor, amended | 0001193125-26-388676 |
| 2026-09-01 | 18:40 ET | [SCHEDULE 13D/A](/filings/0001193125-26-378878.md) | Ownership report, active investor, amended | 0001193125-26-378878 |
| 2026-08-05 | 13:56 ET | [10-Q](/filings/0001425450-26-000070.md) | Quarterly report, period 2026-06-30 | 0001425450-26-000070 |
| 2026-08-04 | 16:31 ET | [8-K](/filings/0001425450-26-000067.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000067 |
| 2026-08-04 | 16:08 ET | [8-K](/filings/0001425450-26-000066.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000066 |
| 2026-06-04 | 16:22 ET | [8-K](/filings/0001425450-26-000041.md) | 5.07 Shareholder vote results | 0001425450-26-000041 |
| 2026-05-01 | 15:45 ET | [10-Q](/filings/0001425450-26-000036.md) | Quarterly report, period 2026-03-31 | 0001425450-26-000036 |
| 2026-04-30 | 16:12 ET | [8-K](/filings/0001425450-26-000033.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000033 |
| 2026-04-30 | 16:09 ET | [8-K](/filings/0001425450-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000032 |
| 2026-04-20 | 16:57 ET | [DEF 14A](/filings/0001425450-26-000027.md) | Proxy statement, period 2026-04-20 | 0001425450-26-000027 |
| 2026-04-01 | 17:13 ET | [8-K](/filings/0001104659-26-038610.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-038610 |
| 2026-03-04 | 16:50 ET | [10-K](/filings/0001425450-26-000013.md) | Annual report, period 2025-12-31 | 0001425450-26-000013 |
| 2026-02-26 | 16:17 ET | [8-K](/filings/0001425450-26-000010.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000010 |
| 2026-02-26 | 16:13 ET | [8-K](/filings/0001425450-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000009 |
| 2026-01-12 | 07:55 ET | [8-K](/filings/0001425450-26-000006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-26-000006 |
| 2026-01-12 | 07:12 ET | [8-K](/filings/0001425450-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-26-000003 |
| 2025-10-29 | 13:03 ET | [10-Q](/filings/0001425450-25-000114.md) | Quarterly report, period 2025-09-30 | 0001425450-25-000114 |
| 2025-10-28 | 16:32 ET | [8-K](/filings/0001425450-25-000112.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000112 |
| 2025-10-28 | 16:06 ET | [8-K](/filings/0001425450-25-000111.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000111 |
| 2025-10-09 | 16:06 ET | [8-K](/filings/0001425450-25-000108.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000108 |
| 2025-08-11 | 15:34 ET | [8-K](/filings/0001425450-25-000099.md) | 5.02 Departure or appointment of officers or directors | 0001425450-25-000099 |
| 2025-08-06 | 15:25 ET | [10-Q](/filings/0001425450-25-000096.md) | Quarterly report, period 2025-06-30 | 0001425450-25-000096 |
| 2025-08-05 | 16:33 ET | [8-K](/filings/0001425450-25-000093.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000093 |
| 2025-08-05 | 16:07 ET | [8-K](/filings/0001425450-25-000092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000092 |
| 2025-08-05 | 16:03 ET | [8-K](/filings/0001425450-25-000090.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000090 |
| 2025-05-27 | 12:19 ET | [8-K](/filings/0001425450-25-000059.md) | 5.07 Shareholder vote results | 0001425450-25-000059 |
| 2025-05-14 | 09:06 ET | [8-K](/filings/0001425450-25-000056.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001425450-25-000056 |
| 2025-05-08 | 15:37 ET | [10-Q](/filings/0001425450-25-000052.md) | Quarterly report, period 2025-03-31 | 0001425450-25-000052 |
| 2025-05-07 | 16:14 ET | [8-K](/filings/0001425450-25-000048.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000048 |
| 2025-05-07 | 16:07 ET | [8-K](/filings/0001425450-25-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000047 |
| 2025-04-02 | 10:06 ET | [DEF 14A](/filings/0001425450-25-000033.md) | Proxy statement, period 2025-04-02 | 0001425450-25-000033 |
| 2025-03-06 | 10:45 ET | [8-K](/filings/0001425450-25-000017.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000017 |
| 2025-03-05 | 14:15 ET | [10-K](/filings/0001425450-25-000015.md) | Annual report, period 2024-12-31 | 0001425450-25-000015 |
| 2025-03-04 | 16:14 ET | [8-K](/filings/0001425450-25-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000012 |
| 2025-01-14 | 08:12 ET | [8-K](/filings/0001425450-25-000009.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-25-000009 |
| 2025-01-13 | 16:07 ET | [8-K](/filings/0001425450-25-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-25-000005 |
| 2024-11-12 | 10:25 ET | [8-K](/filings/0001425450-24-000096.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-24-000096 |
| 2024-11-07 | 14:37 ET | [10-Q](/filings/0001425450-24-000094.md) | Quarterly report, period 2024-09-30 | 0001425450-24-000094 |
| 2024-11-06 | 16:11 ET | [8-K](/filings/0001425450-24-000090.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-24-000090 |
| 2024-10-18 | 16:12 ET | [8-K](/filings/0001425450-24-000087.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001425450-24-000087 |
| 2024-09-12 | 10:32 ET | [8-K](/filings/0001425450-24-000085.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-24-000085 |
| 2024-08-12 | 16:01 ET | [8-K](/filings/0001104659-24-088333.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-088333 |
| 2024-08-09 | 09:25 ET | [8-K](/filings/0001425450-24-000081.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001425450-24-000081 |
| 2024-08-06 | 14:39 ET | [10-Q](/filings/0001425450-24-000079.md) | Quarterly report, period 2024-06-30 | 0001425450-24-000079 |
| 2024-08-05 | 17:09 ET | [8-K](/filings/0001425450-24-000077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001425450-24-000077 |
| 2024-08-05 | 16:31 ET | [8-K](/filings/0001104659-24-085842.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-085842 |
| 2024-05-28 | 11:34 ET | [8-K](/filings/0001425450-24-000038.md) | 5.07 Shareholder vote results | 0001425450-24-000038 |
| 2024-05-28 | 08:00 ET | [8-K](/filings/0001104659-24-065338.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-065338 |

Page 1 of 5. [Older](/companies/kids/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:17 ET. No prices; not investment advice.